Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways
Malignant ascites is commonly produced in advanced epithelial ovarian cancer (EOC) and serves as unique microenvironment for tumour cells. Acellular ascites fluid (AAF) is rich in signalling molecules and has been proposed to play a role in the induction of chemoresistance. Through in vitro testing...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2025-01-01
|
| Col·lecció: | Molecular Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/1878-0261.13726 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
